(Q47997377)

7 February 2018

title

Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders (English)

1 reference

7 February 2018

1 reference

4

1 reference

7 February 2018

author name string

R L Carhart-Harris

series ordinal

1

1 reference

7 February 2018

S Brugger

series ordinal

2

1 reference

7 February 2018

D J Nutt

series ordinal

3

1 reference

7 February 2018

language of work or name

English

0 references

publication date

19 June 2013

1 reference

7 February 2018

Journal of Psychopharmacology

published in

1 reference

7 February 2018

volume

27

1 reference

7 February 2018

issue

9

1 reference

7 February 2018

page(s)

771-778

1 reference

7 February 2018

User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

From drugs to deprivation: a Bayesian framework for understanding models of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

The amphetamine-induced sensitized state as a model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

Transients, metastability, and neuronal dynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

History, rationale and potential of human experimental hallucinogenic drug research in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

The negative symptoms of schizophrenia: category or continuum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

A bayesian foundation for individual learning under uncertainty

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

Assessing clinical implications of spiritual experiences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

Impact of concurrent alcohol misuse on symptom presentation of acute mania at initial evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

Glutamate and dopamine dysregulation in schizophrenia--a synthesis and selective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

Self-reported psychopathology in polydrug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

Methamphetamine activates reward circuitry in drug naïve human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

Acute psychosis caused by dextro-amphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494107

21 January 2018

Identifiers

DOI

10.1177/0269881113494107

1 reference

7 February 2018

1 reference

7 February 2018